Soluble CD14 Enhances Membrane CD14-Mediated Responses to Peptidoglycan: Structural Requirements Differ from Those for Responses to Lipopolysaccharide
Open Access
- 1 September 2000
- journal article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 68 (9) , 5254-5260
- https://doi.org/10.1128/iai.68.9.5254-5260.2000
Abstract
The purpose of this study was to identify the functional significance of the binding of soluble CD14 (sCD14) to bacterial peptidoglycan (PGN) and to compare the structural requirements of sCD14 for the binding to PGN and lipopolysaccharide (LPS) and for sCD14-mediated enhancement of PGN- and LPS-induced cell responses. sCD14 did not facilitate the responses of membrane CD14 (mCD14)-negative pre-B 70Z/3 cells to PGN, although it facilitated the responses of these cells to LPS and although mCD14 facilitated the responses of 70Z/3 cells to PGN. sCD14 enhanced mCD14-mediated cell activation by both PGN and LPS, but only the responses to LPS, and not to PGN, were enhanced by LPS-binding protein. Four 4- or 5-amino-acid-long sequences within the 65-amino-acid N-terminal region of sCD14 were needed for binding to both PGN and LPS and for enhancement of cell activation by both PGN and LPS. However, deletions of individual sequences had different effects on the ability of sCD14 to bind to PGN and to LPS and on the ability to enhance the responses to PGN and to LPS. Thus, there are different structural requirements of sCD14 for binding to PGN and to LPS and for the enhancement of PGN- and LPS-induced cell activation.Keywords
This publication has 24 references indexed in Scilit:
- Chemokines Are the Main Proinflammatory Mediators in Human Monocytes Activated by Staphylococcus aureus, Peptidoglycan, and EndotoxinPublished by Elsevier ,2000
- Endothelial and Epithelial Cells Do Not Respond to Complexes of Peptidoglycan with Soluble CD14 but Are Activated Indirectly by Peptidoglycan‐Induced Tumor Necrosis Factor‐α and Interleukin‐1 from MonocytesThe Journal of Infectious Diseases, 1998
- Mutation of Amino Acids 39–44 of Human CD14 Abrogates Binding of Lipopolysaccharide and Escherichia coliEuropean Journal of Biochemistry, 1997
- Differential Activation of Extracellular Signal-Regulated Kinase (ERK) 1, ERK2, p38, and c-Jun NH2-Terminal Kinase Mitogen-Activated Protein Kinases by Bacterial PeptidoglycanThe Journal of Infectious Diseases, 1996
- CD14 Is a Cell-activating Receptor for Bacterial PeptidoglycanJournal of Biological Chemistry, 1996
- Catalytic Properties of Lipopolysaccharide (LPS) Binding ProteinPublished by Elsevier ,1996
- Identification of a Lipopolysaccharide Binding Domain in CD14 between Amino Acids 57 and 64Published by Elsevier ,1995
- [20] Isolation of peptidoglycan and soluble peptidoglycan fragmentsPublished by Elsevier ,1994
- Lipopolysaccharide (LPS)-binding protein accelerates the binding of LPS to CD14.The Journal of Experimental Medicine, 1994
- CD14, a Receptor for Complexes of Lipopolysaccharide (LPS) and LPS Binding ProteinScience, 1990